Insider trades
Jeetinder Singh Mahal, CEO of Jasper Therapeutics JSPR, has filed 0 purchases and 5 sales on the open market. The latest trade was on 02/06.
Jeetinder Singh Mahal
CEO and President
- Company
- Jasper Therapeutics JSPR
- First filing
- 23/03/20
- Trades
- 23 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- No record
- Last trade
- 02/06
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 24/12/12 | 24/12/12 | 900 sh | $22.11 | $19,899 | −3.5% | |
| Open-market sale10b5-1 plan | 24/09/12 | 24/09/12 | 900 sh | $21.23 | $19,107 | −3.5% | |
| Open-market sale10b5-1 plan | 24/06/12 | 24/06/12 | 900 sh | $24.16 | $21,744 | −3.5% | |
| Open-market sale | 24/03/12 | 24/03/12 | 900 sh | $26.44 | $23,796 | −3.5% | |
| Open-market sale10b5-1 plan | 23/06/13 | 23/06/13 | 9,000 sh | $1.66 | $14,940 | −3.0% |